Fulgent Genetics, Inc. (FLGT) Operating cash flow 2016–2025
Fulgent Genetics, Inc. (FLGT) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$101.6MFY2025 · since FY2016: $4.4M → -$101.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$101.6M | -582.6% |
| FY2024 | $21.1M | -22.0% |
| FY2023 | $27.0M | -89.3% |
| FY2022 | $253.5M | -52.9% |
| FY2021 | $538.6M | +283.0% |
| FY2020 | $140.6M | +2449.0% |
| FY2019 | $5.5M | +917.3% |
| FY2018 | -$675,000 | -150.7% |
| FY2017 | $1.3M | -69.8% |
| FY2016 | $4.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice